#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy – Endpoints News

#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy  Endpoints NewsThe Next Frontier for Obesity Drugs Isn’t How Much Weight You Lose, but What Kind  WSJRegeneron weight-loss drug halves muscle loss in combination with Novo’s semaglutide in trial  ReutersPhase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss  The Manila TimesPharma deals and data heat the weight-loss-drug market  Chemical & Engineering News